IL231070A0 - ליגנדות לרצפטור האסטרוגן ושיטות לשימושם - Google Patents

ליגנדות לרצפטור האסטרוגן ושיטות לשימושם

Info

Publication number
IL231070A0
IL231070A0 IL231070A IL23107014A IL231070A0 IL 231070 A0 IL231070 A0 IL 231070A0 IL 231070 A IL231070 A IL 231070A IL 23107014 A IL23107014 A IL 23107014A IL 231070 A0 IL231070 A0 IL 231070A0
Authority
IL
Israel
Prior art keywords
methods
estrogen receptor
estrogen
receptor
Prior art date
Application number
IL231070A
Other languages
English (en)
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Application filed by Gtx Inc filed Critical Gtx Inc
Publication of IL231070A0 publication Critical patent/IL231070A0/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL231070A 2011-08-23 2014-02-20 ליגנדות לרצפטור האסטרוגן ושיטות לשימושם IL231070A0 (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (1)

Publication Number Publication Date
IL231070A0 true IL231070A0 (he) 2014-03-31

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231070A IL231070A0 (he) 2011-08-23 2014-02-20 ליגנדות לרצפטור האסטרוגן ושיטות לשימושם

Country Status (10)

Country Link
EP (1) EP2747562A4 (he)
JP (1) JP2014524479A (he)
KR (1) KR20140064906A (he)
CN (1) CN103957706A (he)
AU (1) AU2012312902B2 (he)
CA (1) CA2845890A1 (he)
IL (1) IL231070A0 (he)
IN (1) IN2014DN01959A (he)
MX (1) MX2014002105A (he)
RU (1) RU2014111060A (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018342909B2 (en) * 2017-09-27 2023-06-08 Targimmune Therapeutics Ag Castration resistant prostate cancer
US20230174662A1 (en) * 2019-02-01 2023-06-08 Fondazione Per L'istituto Oncologico Di Ricerca (Ior) Methods of treating castrate-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008006885A (es) * 2005-11-28 2008-10-20 Gtx Inc Agentes de enlace de receptores nucleares.
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
WO2010096801A1 (en) * 2009-02-23 2010-08-26 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Also Published As

Publication number Publication date
KR20140064906A (ko) 2014-05-28
AU2012312902B2 (en) 2016-03-17
CA2845890A1 (en) 2013-03-28
EP2747562A4 (en) 2015-05-06
MX2014002105A (es) 2014-09-25
CN103957706A (zh) 2014-07-30
JP2014524479A (ja) 2014-09-22
AU2012312902A1 (en) 2013-05-23
RU2014111060A (ru) 2015-09-27
IN2014DN01959A (he) 2015-05-15
EP2747562A1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
HK1255608A1 (zh) 抗htra1抗體及使用方法
IL227440B (he) מכשיר תומכן כדורי ושיטות לשימוש
HK1198165A1 (en) Fluorinated estrogen receptor modulators and uses thereof
EP2721063A4 (en) PCSK9 BINDING POLYPEPTIDES AND METHOD OF USE THEREOF
PT2683731T (pt) Derivados de triterpenóides c4-monometil e os métodos de utilização dos mesmos
EP2670866A4 (en) BIOMARKERS AND METHODS OF USE
HK1201843A1 (en) Anti-polyubiquitin antibodies and methods of use
ZA201403760B (en) Anti-cd98 antibodies and methods of use thereof
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
EP2776437A4 (en) MODULATORS OF OPIOID RECEPTORS AND METHOD FOR THEIR USE
EP2558496A4 (en) ANTIBODIES TO POLYUBIQUITINE AND METHOD FOR THEIR USE
ZA201300174B (en) Anti-neuropilin antibodies and methods of use
EP2538780A4 (en) STROGEN RECEPTOR LIGANDS AND METHODS OF USE
EP2709999A4 (en) QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE
EP2670245A4 (en) ALPHA-CÉTOHÉTÉROCYCLES AND METHODS OF MAKING AND USING THEM
IL231070A0 (he) ליגנדות לרצפטור האסטרוגן ושיטות לשימושם
EP2776462A4 (en) INDOLALKYLAMINO WITHASTEROID CONJUGATES AND USE METHOD THEREFOR